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ABSTRACT 
 
Ectodermal organs, such as teeth and hair, share common developmental mechanisms. They 
all begin organogenesis as two adjacent tissue layers, the epithelium and the mesenchyme. An 
epithelial thickening, a placode, is formed, which then will bud into or out of the 
mesenchyme. Morphogenesis continues as a co-ordinated process of epithelial folding and 
branching, mesenchymal condensation, and differentiation of both tissues. The development 
of these organs is regulated by interactions between the epithelium and the mesenchyme, and 
by the transient signalling centres that form in the epithelium. Several common signalling 
factors from the BMP, FGF, Hh, and Wnt families are required for their development. Studies 
performed in this thesis and by others have shown that members of the TNF signalling 
pathway also contribute to ectodermal organogenesis. 
 
Ectodermal dysplasias are congenital diseases where at least two ectodermal appendages are 
defective. In this study the murine gene, Tabby, for one of these dysplasias, X-linked 
hypohidrotic ectodermal dysplasia (HED or EDA), was cloned and shown to be a member of 
the TNF superfamily. The protein product was named ectodysplasin. The ectodysplasin 
mRNA expression pattern was studied initially in teeth and hair, and also in other embryonic 
tissues comparing it to its receptor, Edar. Ectodysplasin was expressed in the epithelium of 
the developing tooth, hair, lacrimal gland, and brain. However, in the salivary gland the 
mRNA was found in the mesenchyme. Edar expression was always found in the epithelium. 
The expression patterns suggest that ectodysplasin-Edar signalling can occur both between 
epithelial compartments and between the epithelium and the mesenchyme. 
 
Tabby, the mouse ectodysplasin mutant, has defective tooth formation, specifically the cusp 
number of the first molars is reduced. Analysis of the molar tooth phenotype with molecular 
markers showed a reduction in the size of the tooth signalling center, the enamel knot. This 
gives support to the hypothesis that the enamel knot controls the size of the tooth crown. The 
reduction in Tabby molar cusp number could be partially rescued in vitro by application of 
exogenous FGF. 
 
The potential role of other TNF signalling molecules was explored by studying the mRNA 
expression pattern of a TNF receptor, TNFRSF19, related to Edar. TNFRSF19 was co-
expressed with Edar in the tooth, mammary glands, whiskers, and the limb bud suggesting 
that the two receptors may be functionally redundant in these organs. 
 
Overexpression of Edar in transgenic mice affected tooth and hair formation in a dose-
dependent manner. The primary hair follicle formation was inhibited, possibly by the 
upregulation of BMP4 throughout the developing hair epithelium. 
 
In summary, work in this thesis includes the cloning of a novel protein involved in ectodermal 
organogenesis, ectodysplasin, a TNF superfamily member. The expression pattern of 
ectodysplasin and other TNF signalling pathway members was studied with in situ 
hybridisation. In vitro and in vivo studies with mutant and transgenic mice tissues have 
contributed to knowledge about this developmentally new signalling mechanism. 
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1. REVIEW OF THE LITERATURE 
 
1.1. Ectodermal organ development 
 
Teeth and hair have little in common in appearance, but developmentally they resemble each 
other considerably. Together with whiskers, feathers, scales, and mammary, sweat, lacrimal 
and salivary glands they derive from the ectoderm, and are thus called ectodermal organs (for 
reviews, see Chuong 1998; Millar 2002; Thesleff and Mikkola 2002; Pispa and Thesleff 2003; 
Veltmaat et al. 2003). The early morphogenesis of all ectodermal organs begins from two 
adjacent tissue layers, the epithelium and the mesenchyme, and inductive interactions between 
these tissue layers direct development in a sequential manner (Figure 1).  
 
 
 
                                        
 
Figure 1. Development of ectodermal organs. 
 
Morphologically very different organs, such as tooth, hair, mammary gland, and feather, develop from two 
adjacent layers: the epithelium (E) and the mesenchyme (M). An epithelial placode is formed, which then buds 
either into or out of the mesenchyme. During morphogenesis the epithelium and the mesenchyme proliferate and 
branch determining the final shape of the organ. 
 
 
In most organs, the first signals instructing organ formation derive from the mesenchyme. An 
ectodermal placode is then formed by a local thickening of the epithelium. The placode will 
direct underlying mesenchymal cells to condense around the placode and to form a so-called 
papilla. The placode grows into an ectodermal bud, which projects either into (e.g. hairs) or 
out of (feathers) the mesenchyme. Subsequent folding and growth of the epithelium and the 
mesenchyme will contribute to the final shape of the organ, accompanied by organ-specific 
differentiation. The placode can be seen as a signalling center as it specifically expresses 
several growth factors. 
 
The last twenty years of developmental biology have shown that members of the four signal 
transduction families, bone morphogenetic protein (BMP), fibroblast growth factor (FGF), 
hedgehog (Hh), and Wnt families are repeatedly required for development. Ectodermal organs 
are no exception to this rule (Millar 2002; Thesleff and Mikkola 2002; Pispa and Thesleff 
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2003). It is interesting that the expression patterns of many of these signals are also conserved 
between different types of organs. For example, alligator scale placodes express Shh and 
Bmp2 in a very similar manner as chicken and duck scales and feathers (Harris et al. 2002). 
 
1.1.1. Tooth development 
 
Mammalian teeth develop from the oral ectoderm and the underlying neural crest-derived 
mesenchyme in the fronto-nasal process and the first branchial arch (Thesleff and Mikkola 
2002; Cobourne and Sharpe 2003). Teeth can only form within the limits of the dental lamina, 
a U-shaped epithelial ridge in both maxilla and mandible. Four different types of teeth exist: 
incisors, canines, premolars, and molars. In each jaw quarter humans have two incisors, one 
canine, two premolars and three molars, whereas mice have only one incisor and three molars. 
Between the murine incisors and molars is a toothless diastema region. In the maxillary 
diastema tooth development is initiated but it soon ceases, and the diastema tooth buds 
degenerate by apoptosis (Keränen et al. 1999). 
 
Hox proteins are involved in patterning of the vertebrate anterior-posterio body axis. In the 
maxilla and mandible it seems that the distalless homeobox proteins (Dlx) are required for 
patterning instead of Hox proteins. Dlx genes are expressed in overlapping domains 
throughout the first branchial arch. Dlx1/Dlx2 mutant mice do not develop maxillary molars, 
and Dlx5/Dlx6 mutant mandibles have maxillary identity (Thomas et al. 1997; Depew et al. 
2002). The identity of molars versus incisors may also be determined by mesenchymally 
expressed transcription factors, as ectopic Barx1 expression seems to transform incisors into 
molars (Tucker et al. 1998). The molecules determining identity of canines and premolars in 
e.g. humans are not known. 
 
Tooth development can be divided into the initiation, bud, cap, and bell stages, named after 
the appearance of the epithelial component (Figure 2). In mouse molar teeth the initiation 
stage begins at embryonic day 11 (E11) when the lamina thickens to form a placode at the site 
of the future first molar. Mesenchymal cells will then condense around the epithelial placode 
to form a papilla, which is accompanied by upregulation of cellular proliferation and 
expression of extracellular matrix molecules such as syndecan and tenascin-C (Vainio and 
Thesleff 1992; Sahlberg et al. 2001). 
 
Tissue recombination experiments have shown that the first identifiable inductive signal 
comes from the epithelium in contrast to most other ectodermal organs (Mina and Kollar 
1987; Lumsden 1988). However, transplantation of mouse pre-migratory neural crest cells 
into chick embryos can induce tooth-like structures in the normally toothless chick jaw 
(Mitsiadis et al. 2003), suggesting that early mesenchymal signals may also be required. The 
exact nature of the first epithelial signal is not known but at least the balance of FGF and 
BMP signalling seems to regulate the sites of tooth formation (Neubüser et al. 1997; Mandler 
and Neubüser 2001). Conditional inactivation of Fgf8 in the first branchial arch ectoderm or 
inhibition of FGF signalling in vitro by an FGFR1-specific inhibitor results in loss of tooth 
development (Trumpp et al. 1999; Mandler and Neubüser 2001). FGFs and BMPs regulate 
several targets in the dental mesenchyme or epithelium, some of them antagonistically. Some 
of these target transcription factors, e.g. Msx1/Msx2, Pax9 and Pitx2, are essential for tooth 
development (Vainio et al. 1993; Neubüser et al. 1997; Tucker et al. 1998; St Amand et al. 
2000; Mandler and Neubüser 2001). 
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Figure 2. Hair and tooth development. 
 
The early stages of hair and tooth development are very similar beginning with the thickening of the epithelium 
to form a placode, which will then bud into the mesenchyme. The hair and tooth epithelia induce the formation 
of the dermal and dental papillae, respectively. Transient signalling centers form in the placode and at the tip of 
the bud. The hair bud will then grow to encircle the dermal papilla. Matrix cells in the epithelium contribute to 
the formation of the hair shaft, and epidermal stem cells reside in the bulge. During cap stage of tooth 
development the primary enamel knot forms in the epithelial organ. Epithelial cervical loops are sites of active 
proliferation. Secondary enamel knots are seen at the bell stage directing the shaping of the tooth crown. 
 
 
Transient epithelial signalling centres are seen first in the placode, and later at the bud stage at 
the tip of the invaginating bud (Figure 2). Around this time the potential to direct 
odontogenesis shifts to the mesenchyme. The tooth placode expresses several signalling 
molecules (Jernvall and Thesleff 2000; Thesleff and Mikkola 2002). Precise functions for all 
of these in the placode have not been discovered but at least placodal BMP signalling is 
essential for tooth development. Epithelial BMP4 upregulates the expression of mesenchymal 
Bmp4 via the transcription factor Msx1, which is required for tooth development (Vainio et al. 
1993; Satokata and Maas 1994; Chen et al. 1996). Mesenchymal BMP4 further stimulates 
Lef1 in the mesenchyme, and Lef1 mutants have no teeth (van Genderen et al. 1994; 
Kratochwil et al. 1996). Shh is also expressed in the tooth placode, but its role there is not 
entirely clear. Wnt7a is expressed adjacent to Shh in the oral epithelium. Overexpression of 
Wnt7b in the ectoderm results in lack of Shh expression and absence of tooth formation 
(Sarkar et al. 2000). Similarly, inhibition of Shh with antibodies or inhibitors arrests tooth 
development (Cobourne et al. 2001). On the other hand, transgenic mice overexpressing 
BMP4 show no detectable Shh expression in the early mandible and nevertheless have no 
tooth defects (Zhang et al. 2000). It is of course possible that the lack of Shh signalling can be 
compensated by the downstream effects of BMP overexpression. 
 
At cap stage the signalling centre is called the primary enamel knot, and the cells of the knot 
can be distinguished histologically by their condensed appearance, and by their lack of 
proliferation. It has been postulated that mesenchymal signals, such as BMP4, regulate the 
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formation of the enamel knot. Exogenous BMP4 can induce the expression of two enamel 
knot markers, Msx2 and p21 (Jernvall et al. 1998; Bei et al. 2000). All in all, the enamel knot 
expresses specifically at least 15 different signalling factors and transcription factors that 
regulate either the shaping of the tooth crown or the function of the enamel knot itself (Pispa 
and Thesleff 2003). One of them, LEF1, has been shown to have one specific function in the 
knot: to induce Fgf4 (Kratochwil et al. 2002). FGF4 can upregulate mesenchymal FGFs 
(Kettunen et al. 2000), which are missing in Lef1 mutant teeth (Kratochwil et al. 2002). 
Mesenchymal FGFs stimulate epithelial proliferation in the epithelial cervical loops (Jernvall 
et al. 1994; Kettunen et al. 2000). Shh, which is expressed in the enamel knot, affects 
proliferation of the lingual cervical loop, but conditional inactivation of the Shh receptor, 
Smoothened, in the epithelium does not inhibit cervical loop growth indicating that the effect 
on proliferation is achieved via the mesenchymally expressed Smoothened (Dassule et al. 
2000; Gritli-Linde et al. 2002). Thus, promotion of epithelial proliferation by Wnt and Shh 
signalling is regulated by the enamel knot but mediated via the mesenchyme. Subsequently 
the enamel knot is removed by apoptosis (Jernvall et al. 1994; Vaahtokari et al. 1996ab). 
 
At the bell stage new signalling centres, secondary enamel knots, form. Their locations 
correlate well with the sites of the future cusps, which are the highest peaks of the molar tooth 
crown (Jernvall et al. 2000). Dental hard tissues, dentin and enamel, will then be deposited by 
the differentiated mesenchymal odontoblasts and epithelial ameloblasts respectively. Terminal 
differentiation of odontoblasts and ameloblasts is governed by interactions between the 
epithelium and mesenchyme (Thesleff and Hurmerinta 1981). The integrity of the 
extracellular matrix between the epithelium and mesenchyme is also crucial for ameloblast 
differentiation, for example mutations in laminin 5 disrupt enamel formation (Ryan et al. 
1999). Shh is implicated also at this stage since conditional Shh mutants have disrupted 
enamel (Dassule et al. 2000). 
 
The study of stem cells in teeth is an area of active research, particularly because of the 
potential clinical applications. The rodent incisor has been a good model to study dental stem 
cells as it grows continuously. The continuous growth has been attributed to stem cells 
regulated by FGF10 and Notch signalling (Harada et al. 1999, 2002; Tummers and Thesleff 
2003). 
 
1.1.2. Hair development 
 
There is considerable variability in the structure, shape, cycling, and patterning of hairs in 
different species. Even within one individual several hair types can be found. For example, 
mouse pelage hair is a mixture of four different types of hairs: guard hairs, awls, auchenes, 
and zigzags. Zigzags (circa 60-70% of all hairs) and awls (circa 30%) are most numerous, 
whereas auchenes (circa 5-10%) and guard hairs (2%) are much rarer (Fraser 1951). The hair 
types can be differentiated from each other by their length, shape, width, and the timing of 
their development. Guard hair follicles initiate development at E14, awls at E17, and zigzags 
and auchenes begin to develop in newborn skin (Mann 1962). 
 
Despite the diversity in form all hair follicles develop in a very similar sequence (Figure 2) 
(Hardy 1992; Millar 2002). A placode forms in the epidermis and buds into the underlying 
dermis. The base of the bud encircles the mesenchymal dermal papilla. The hair matrix, 
immediately next to the papilla, is the source of epithelial cells, which will then migrate 
upward and differentiate into the concentric layers of the mature hair follicle. 
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Tissue recombination experiments have shown that prior to placode formation only the 
mesenchyme is capable of directing hair development (the first dermal message) (Kollar 
1970; Hardy 1992). When the bud has formed the inductive potential shifts to the epithelium 
(the epidermal signal), and thereafter back to the mesenchyme (the second dermal message). 
The epidermal signal will induce the dermal papilla, and the second dermal message enhances 
epithelial cell proliferation and growth of the hair bud. 
 
The nature of the first dermal message is not known but there is some indication that Wnt 
signalling may be involved in hair and feather development. Wnt11 is expressed in the dermis 
of the chicken feather-forming field prior to placode formation. Signals from the neural tube, 
specifically Wnt1, can induce feather formation and Wnt11 expression (Olivera-Martinez et 
al. 2002). Also β-catenin is transiently found in the chicken dermis prior to placode formation 
(Noramly et al. 1999). Transgenic mice overexpressing Dickkopf1, an inhibitor of Wnt 
signalling, have no hairs, teeth or mammary glands (Andl et al. 2002). LEF1 null mice have 
defects in hair formation and an absence of teeth and mammary glands (van Genderen et al. 
1994). 
 
The epithelial placode can be seen as a central unit of ectodermal organogenesis. A reaction-
diffusion model has been put forward for hair and feather development that proposes that the 
initial (mesenchymal) signals are expressed throughout the prospective morphogenetic field 
(Turing 1952; Koch and Meinhardt 1994; Barsh 1999; Jiang et al. 1999). These signals 
activate both positive and negative regulators of placode development, which will compete 
with each other both in the placode epithelium and the underlying mesenchyme. At the site of 
the placode the activity of the negative regulators is repressed, and placode formation is 
promoted. However, the negative regulators are free to diffuse to the interfollicular epidermis 
and repress placode formation there. The mechanisms of reaction-diffusion and lateral 
inhibition must be exactly integrated to achieve the regular array of forming hair and feather 
follicles. 
 
Wnts may act as positive regulators of hair placode formation. Overexpression of β-catenin 
causes ectopic hair follicle formation (Gat et al. 1998), and lack of β-catenin in the epidermis 
results in lack of hair follicles (Huelsken et al. 2001). In these experiments it is of course not 
possible to differentiate between the potential role of Wnt as a mesenchymal inducer and as a 
placode promoter. FGF signalling can also promote placode formation. FGF2 beads induce 
feather follicle formation (Widelitz et al. 1996), and mice mutant for the FGF receptor Fgfr2b 
have abnormal hair follicles (Petiot et al. 2003). 
 
BMPs seem to act as placode inhibitors. For example, beads releasing BMP4 on embryonic 
skin explants inhibit hair follicle formation (Botchkarev et al. 1999). Although BMPs are 
expressed in the placode itself, their activity within the placode is believed to be negated by 
BMP inhibitors. Increasing or decreasing Noggin levels has the same effect on follicle 
formation as decreasing or increasing BMP activity, respectively (Botchkarev et al. 1999, 
2002). In addition to BMPs, TGFβ1 also seems to inhibit hair follicle formation. Tgfβ1 null 
mice have slightly advanced hair follicle development, and beads of TGFβ1 inhibit follicle 
formation in vitro (Foitzik et al. 1999). 
 
Several genes are known whose mutations affect the structure and shape of hairs (Sundberg 
1994; Millar 2002). Nevertheless, little is known about the signalling events regulating 
terminal differentiation of hair. Wnt signalling appears to be important again at this stage as 
LEF1 binds to the promoters of the hair-specific keratins and seems to enhance their 
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expression levels (Zhou et al. 1995; Dunn et al. 1998). BMPs may also be involved, as 
manipulating BMP activity causes hair shaft differentiation defects (Blessing et al. 1993; 
Kulessa et al. 2000). In addition, proper regulation of adhesion and extracellular proteins is 
necessary for hair differentiation as shown by mice mutant for β1 integrin or laminin-10 
(Raghavan et al. 2000; Li et al. 2003). 
 
In contrast to mammalian teeth, new hairs are produced throughout life. Each hair follicle 
goes through a cycle of development, and new follicles are formed from the remains of the 
old follicle. Each hair cycle consists of three phases: anagen, the active growth phase, 
catagen, the degenerative phase, and telogen, the resting phase. The continuous formation of 
new follicles is ensured by the epidermal stem cells, which reside in the bulge halfway along 
the length of the follicle. These stem cells can migrate down to the hair matrix but they also 
contribute to the formation of sebaceous glands and epidermis (Fuchs et al. 2001; Alonso and 
Fuchs 2003). Changes in hair cycle can affect hair length. FGF5 is a negative regulator of the 
hair cycle as long-haired angora mice have a mutation in the Fgf5 gene (Hebert et al. 1994). 
Proper regulation of the EGF signalling has been suggested to be involved in the 
telogen/anagen and anagen/catagen transitions (Mak and Chan 2003). Wnt signalling has been 
associated with regulating stem cell fate (Merrill et al. 2001; Niemann et al. 2002). 
 
1.2. Ectodermal dysplasias in humans and mice 
 
Ectodermal dysplasias are congenital defects where the development of two or more 
ectodermal organs is abnormal. There are over 150 clinically defined dysplasias (Pinheiro and 
Freire-Maia 1994; Priolo and Lagana 2001). Organs most commonly affected are the hair and 
teeth, which of course are also the easiest to score. Defects include missing or hypoplastic hair 
follicles of the scalp, eyebrows, and lashes, hypodontia of the teeth, absent or reduced 
sweating, and hypoplastic nails, and they are occasionally linked with limb defects, 
immunological aberrations, cleft lip or cleft palate and mental retardation. The genetic and 
molecular study of these syndromes should identify some of the regulatory molecules 
common to and possibly specific for ectodermal organs. 
 
The most common of the ectodermal dysplasias is the X-linked hypohidrotic ectodermal 
dysplasia (HED or EDA; OMIM 305100). It occurs at an estimated incidence of one case per 
100 000 births (Clarke 1987). Since it is X-linked the patients are generally male, but the 
heterozygous carrier females exhibit some symptoms of the disorder. The autosomal forms of 
HED are symptomatically identical to the X-linked form (Munoz et al. 1997). Diagnosis of 
patients is often done when the eruption of the primary teeth is delayed in the early childhood. 
The patients usually have absence of several deciduous and permanent teeth. The hair is 
sparse and fine and often associated with premature male balding. The most severe symptom 
that warrants natal diagnosis is the lack of sweat glands, and therefore the risk of 
hyperthermia. Undiagnosed this symptom is the cause of the 30% early childhood lethality 
associated with HED. Adult patients suffer from heat intolerance but have no increased 
mortality rates (Clarke et al. 1987). 
 
Three mouse models exist that mimic HED: Tabby, downless, and crinkled (Falconer et al. 
1951; Falconer 1952; Philips 1960; Mouse Genome Database (MGD)). These were first 
suggested to be the mouse counterparts of the human HEDs by their similar phenotype and by 
the syntenically similar gene locuses (Blecher 1986). Later the cloning of the genes behind 
these syndromes confirmed this (I, II; Kere et al. 1996; Ferguson et al. 1997; Headon and 
Overbeek 1999; Monreal et al. 1999; Headon et al. 2001; Yan et al. 2002). 
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Tabby/downless/crinkled (Ta/dl/cr) mice may have missing incisors and third molars, and the 
cusps of their molars are reduced in number (Grüneberg 1965). The first and last waves of 
hair follicle formation are missing so that the adult mice lack guard hairs and zigzags 
(Falconer et al. 1951; Falconer 1953; Claxton 1967; Vielkind and Hardy 1996; Laurikkala et 
al. 2002). Several glands are missing, small, or abnormally shaped. These include the sweat 
glands (normally only in the palms of mouse paws), lacrimal and Meibomian glands, and 
submandibular salivary gland (Grüneberg 1971; Blecher et al. 1983). 
 
Thirteen of the genes responsible for ectodermal dysplasias have been identified during the 
last few years (Table 1). Five of them are associated with the tumor necrosis factor (TNF) 
pathway (see results and reviews by Mikkola and Thesleff 2003 and Smahi et al. 2002). The 
rest include the adhesion molecules plakophilin-1 (McGrath et al. 1997), nectin-1 (Suzuki et 
al. 2000), and connexin-30 (Lamartine et al. 2000), the transciption factor p63 (Celli et al. 
1999) and the structural molecules keratins 6A, 6B, 16 and 17 (Bowden et al. 1995; McLean 
et al. 1995; Smith et al. 1998) 
 
Table 1. Mutated genes in ectodermal dysplasias
Gene Type of protein Ectodermal dysplasia OMIM no References
Eda (ectodysplasin) TNF superfamily X-linked HED or EDA 305100 Kere et al. 1996
member Bayés et al. 1998
Edar TNFR superfamily Autosomal recessive 224900 Monreal et al. 1999
member HED
Autosomal dominant 129490 Monreal et al. 1999
HED
Edaradd DD containing adaptor Autosomal recessive 224900
protein HED 2001
IκBα Inhibitor of NFκB EDA-ID Courtois et al. 2003
IKKγ or NEMO Subunit of IKK Incontinentia pigmenti 308300 Smahi et al. 2000
OL-EDA-ID 300301 Döffinger et al. 2001
HED-ID 300291 Zonana et al. 2000
Plakophilin 1 Cytoplasmic desmosomal Ectodermal dysplasia/ 604536 McGrath et al. 1997
plaque protein skin fragility symdrome
Nectin-1 Adherens junction protein ED4 (Margarita Island 225060 Suzuki et al. 2000
type)
Connexin-30 Gap junction component Clouston syndrome 129500 Lamartine et al. 2000
p63 Transcription factor EEC3 604292 Celli et al. 1999
LMS 603543 Van Bokhoven et al.
2001
Split hand/foot malfor- 605289 Ianakiev et al. 2000
mation
AEC 106260 McGrath et al. 2001
ADULT 103285 Amiel et al. 2001
Rapp-Hodgkin syndrome 129400 Kantaputra et al. 2003
Keratins 6A,6B, Structural filamentous Pachyonychia congenita 167200 Bowden et al. 1995
Keratins 16,17 proteins I,II 167210 McLean et al. 1995
Smith et al. 1998
Headon and Overbeek
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1.3. Tumor necrosis factor (TNF) signalling 
 
1.3.1. TNF superfamily 
 
The first TNF molecule isolated, TNFα, was characterised by its ability to kill tumour cells, 
hence its name “tumor necrosis factor” (Pennica et al. 1984). Thereafter TNFα homologues 
that do not all share the tumour cell killing ability have been isolated. The TNF superfamily 
currently consists of 19 TNF-related ligands, listed in http://www-
personal.umich.edu/~ino/List/996.htm (Locksley et al. 2001; Bodmer et al. 2002). They are 
type II membrane proteins (the N-terminus is intracellular) and consist of four domains: the 
intracellular part, the transmembrane domain, the stalk region, and the conserved TNF 
domain. The intracellular portion is generally short (10-80 aa) and does not contain any 
recognisable protein domains (Bodmer et al. 2002). Although it has been suggested that some 
TNF ligands can “reverse signal” back to the cell which expresses them (Cayabyab et al. 
1994; van Essen et al. 1995; Wiley et al. 1996; Orengo et al. 1997) in general the intracellular 
domain is not believed to have any signalling activity. The extracellular circa 150 aa long 
TNF domain is composed of anti-parallel β-strands and is responsible for trimer formation 
and receptor binding (Banner et al. 1993; Cha et al. 2000; Hymowitz et al. 2000; Bodmer et 
al. 2002). Generally, the trimers are homotrimers, but one exception is known: lymphotoxin-
α (LT-α) can form heterotrimers with LT-β (Browning et al. 1993). Between the 
transmembrane domain and the TNF domain lays a stalk area (Bodmer et al. 2002). Some 
TNF ligands are cleaved at the stalk region by proteases such as furin and shed from the 
plasma membrane (Orlinick and Chao 1998). This cleavage is required for a functional 
protein in some cases (Chen et al. 2001; Elomaa et al. 2001; Schneider et al. 2001), but may 
also be used as a means of inhibiting receptor binding and subsequent signalling (Tanaka et 
al. 1998). TNF ligands and members of the C1q family show structural homology indicating 
an evolutionary link (Shapiro and Scherer 1998; Bodmer et al. 2002). 
 
1.3.2. TNF receptors 
 
The TNF receptor (TNFR) superfamily has currently 32 members that are mostly type I 
membrane proteins (their N-terminus resides outside the cell) (Bodmer et al. 2002; Schneider 
et al. 2003). They are listed in http://www-personal.umich.edu/~ino/List/996.htm. The 
cytoplasmic C-terminus has no known enzyme activity. Instead, it can bind cytoplasmic 
adapter proteins and participate in signal tranduction inside the cell (Orlinick and Chao 1998; 
Locksley et al. 2001). The extracellular part of TNF receptors contains a variable number of 
circa 40 aa cysteine-rich domains that are responsible for ligand binding (Orlinick and Chao 
1998; Bodmer et al. 2002). Binding of trimeric TNF ligands has been believed to induce 
clustering of the receptors into trimers and subsequent signal transduction (see references in 
Orlinick and Chao 1998). Current evidence suggests though that self-assembly of receptor 
trimers is required for ligand binding (Chan et al. 2000; Siegel et al. 2000). Some TNF 
ligand/receptor pairs are specific for each other but differential binding also occurs. For 
example, the TRAIL ligand can bind to five different receptors and conversely TNFR1 can 
bind both TNFα and LTα (Bodmer et al. 2002). 
 
Some of the receptors are in soluble or membrane attached form that lack the intracellular part 
(Bodmer et al. 2002). They are believed to act as decoy receptors inhibiting the ligand 
interaction with the functional receptor (Gatanaga et al. 1990; Lantz et al. 1990; Seckinger et 
al. 1990; Simonet et al. 1997; McDermott et al. 1999; Schneider et al. 2003). Regulation of 
the decoy receptor expression may be one means to regulate TNF signalling. 
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1.3.3. Intracellular signal transduction by TNFs 
 
The intracellular signalling network downstream of TNF receptors is complex (Figure 3). It 
consists of a range of adapter proteins and kinases that are used in different combinations 
(Aggarwal 2000; Dempsey et al. 2003). Some of the signal mediators are also utilised by 
other ligands and receptors, for example by the Toll/interleukin-1 receptor family (Toll/IL-
1R) (Cao et al. 1996; Ye et al. 2002). The main cellular responses to TNF signalling include 
apoptosis and the activation of the transcription factors nuclear factor kappa B (NF-κB) and 
activator protein-1 (AP-1) (Dempsey et al. 2003). These transcription factors will then 
translocate into the nucleus and induce (or repress) their respective target genes. Which 
response occurs depends on the ligand, receptor and the cellular context. 
 
 
Figure 3. A simplistic view of some of the 
TNF signal transduction machinery. 
 
Trimeric TNF ligands bind to their trimeric  
membrane receptors, TNFRs. The signal is 
mediated by DD-containing adapter proteins, such 
as FADD, Edaradd, and TRADD, and also TRAF-
proteins. Intracellular molecules, e.g. A20 and c-
Src, modify the signal transduction pathway either 
positively or negatively. Kinases such as IKK, 
JNK, and p38 are required for phosphorylation 
events ensuring the nuclear entry of transcription 
factors NF-κB and AP-1. IκB is an inhibitor of NF-
κB and its phosphorylation and subsequent 
degradation is necessary for NF-κB translocation to 
the nucleus. Final outcomes of TNF signalling 
include apoptosis and transcriptional 
activation/repression of NF-κB and AP-1 target 
genes. 
 
 
 
The intracellular domains of TNF receptors contain potential binding sites for interactions 
with cytosolic proteins (Locksley et al. 2001; Dempsey et al. 2003). The best characterised of 
these sites is the circa 80 aa long death domain (DD) that was first identified because of its 
association with promotion of apoptosis (Tartaglia et al. 1993). The DD domain binds adapter 
proteins such as FADD, TRADD, and Edaradd that share the DD domain. Not all DDs are 
created equal as TNFRs specifically bind certain adapter proteins, e.g. Edar binds only 
Edaradd (Headon et al. 2001; Yan et al. 2002). TRADD, Edaradd and in some circumstances 
FADD can activate NF-κB (Hsu et al. 1995; Hu et al. 2000; Headon et al. 2001; Yan et al. 
2002). FADD and also TRADD can promote apoptosis (Hsu et al. 1995; Kischkel et al. 1995). 
In addition, TRADD activates the Jun N-terminal kinase (JNK), which is a known activator of 
AP-1 (Eliopoulos et al. 1999). 
 
The receptors can also interact with TNF receptor-associated factors (TRAFs) (Inoue et al. 
2000; Chung et al. 2002). The interaction can be direct as has been shown by crystallography 
studies of a CD40 receptor trimer forming a complex with three TRAF molecules (McWhirter 
et al. 1999). The interaction can also be indirect so that another protein links both the TNFR 
and the TRAF molecules (Hsu et al. 1996; Shu et al. 1996; Headon et al. 2001; Yan et al. 
2002). TRAFs have been associated with both the NF-κB and the AP-1 pathways (Inoue et al. 
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2000; Chung et al. 2002; Dempsey et al. 2003). In mammals six TRAFs are known. They are 
expressed in differential patterns, and have potentially different biological functions (Chung 
et al. 2002). 
 
A number of other molecules have been found associated with TNF receptors or with proteins 
interacting with them. The function or importance of many of them is not known, but some 
have been shown to regulate TNF signalling either positively or negatively (Ledgerwood et al. 
1999; Aggarwal 2000). For example, A20 is a zinc finger protein that inhibits TNFα induced 
apoptosis by disrupting apoptotic adapter protein recruitment to the receptor (He and Ting 
2002). At the same time, NF-κB signalling induces its expression (Opipari et al. 1992; Sarma 
et al. 1995). Activation of NF-κB has been shown to protect cells from TNF-induced 
apoptosis (Van Antwerp et al. 1998), and the upregulation of A20 may be one potential 
mechanism for this. 
 
Intracellular kinases are required for activation of the NF-κB and AP-1 transcription factors. 
The main kinases downstream of TNF signalling are the IκB kinase (IKK), and the mitogen-
activated protein kinases such as Jun N-terminal kinase (JNK kinase) and p38 kinase. In 
general, IKK activates NF-κB (Israël 2000), and JNK and p38 kinases AP-1 (Shaulian and 
Karin 2002). The IKK complex consists of a tetramer (or more specifically two dimers) of 
IKKγ (or NEMO) subunits, and two homo- or heterodimers of IKKα and IKKβ (or IKK1 and 
IKK2), the kinase components (Tegethoff et al. 2003). The precise mechanism of how the 
IKK complex is activated is not clear (Israël 2000). A recent report has implicated 
ubiquitination of IKKγ as a potential regulative method (Tang et al. 2003). In addition, NF-κB 
inducing kinase (NIK) seems to be involved in specific activation of IKKα (Regnier et al. 
1997; Ling et al. 1998; Senftleben et al. 2001). c-Src tyrosine kinase has been suggested as 
one way of activating IKKβ (Huang et al. 2003). Indeed, a TNFR, RANK, can activate c-Src 
(Wong et al. 1999), and mice lacking c-Src or expressing a dominant negative Src have a 
similar phenotype to RANK null mice (Soriano et al. 1991; Xing et al. 2001). JNK and p38 
are activated by phosphorylation by a series of MAP kinases (Minden and Karin 1997). 
 
The NF-κB transcription factor is a homo- or heterodimer consisting of proteins of the Rel 
family (relA or p65, relB, c-rel, p50 or NF-κB1, p52 or NF-κB2). p50 and p52 are processed 
from inactive precursors p105 and p100, respectively (Ghosh et al. 1998; Ghosh and Karin 
2002). In the cytosol NF-κB dimer binds to its inhibitor, one of the IκB family members. 
When IκB is degraded, NF-κB is free to translocate from the cytoplasm to the nucleus and 
bind to the promoters of its target genes. The degradation of IκB is accomplished by its 
phosphorylation by the IKK complex (Israël 2000; Ghosh and Karin 2002). IκB degradation 
has been studied to a large degree, and is seen as the canonical NF-κB activation pathway. 
IKKα and IKKβ can both phosphorylate IκB. Analysis of IKKα and IKKβ mutant 
phenotypes has revealed though that the two kinases may compensate for each other in some 
contexts, but they also have more specific functions (Hu et al. 1999b; Li et al. 1999a,b,c; 
Takeda et al. 1999; Tanaka et al. 1999; Pasparakis et al. 2002a,b). Although IKKα seems to 
act via IκB degradation during mammary gland differentiation (Cao et al. 2001) it can also 
activate NF-κB by an alternative pathway. IKKα mediated phosphorylation of the inactive 
precursor, p100, causes p100 proteolysis into the functional subunit, p52 (Senftleben et al. 
2001). In the epidermis it also seems to be able to function in an NF-κB-independent manner 
(Hu et al. 2001). An additional level of regulation of NF-κB activity has been postulated to be 
caused by the phosphorylation of NF-κB subunits (Schulze-Osthoff et al. 1997; Schmitz et al. 
2001; Ghosh and Karin 2002). 
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AP-1 is a homo- or heterodimer composed of members of the Jun, Fos, Maf, or ATF family. 
These proteins contain the bZIP DNA binding motif (Jochum et al. 2001; Shaulian and Karin 
2002). The regulation of AP-1 activity can occur at several levels. Phosphorylation or other 
post-translational modifications can affect protein activity or stability. Transcriptional 
regulation of AP-1 mRNA levels controls the amount of protein available (Karin et al. 1997; 
Shaulian and Karin 2002). TNF stimulated JNK activity seems to affect both protein stability 
and transcriptional regulation (Ventura et al. 2003). 
 
TNF signalling may also interact with other signalling pathways. Tcf/β-catenin signalling is 
required for induction of cyclin D1 by IKKα (Albanese et al. 2003), and glycogen synthase 
kinase-3b (GSK3b), a negative regulator of the Wnt pathway, affects the stability of an NF-
κB precursor (Demarchi et al. 2003). In the chick limb NF-κB has been suggested to mediate 
FGF signalling (Bushdid et al. 2001). A synergistic interaction between TNFα signalling and 
EGFR has also been proposed (Hirota et al. 2001). 
 
1.3.4. The role of TNF signalling 
 
Since the first TNF found, TNFα, could enhance apoptosis of cancerous cells, it raised hopes 
of its use as a therapeutic agent in the treatment of cancer. Further studies have shown though 
that the downstream effects of TNF signalling include not only apoptosis, but also cellular 
proliferation, differentiation, migration (Benoliel et al. 1997; Locksley et al. 2001) and even 
protection from apoptosis (Van Antwerp et al. 1998). The use of TNFα in cancer therapy was 
hindered by its toxic, mainly inflammatory, effects. Indeed, the majority of TNF signalling is 
related to inflammation and to the immune system (Table 2; Pfeffer 2003). Knockouts of 
many of the TNF/TNFRs have impaired immune response or defects in secondary lymphoid 
organs. Of the known TNF ligands, at least 13 are associated with T or B cell activation. 
Although no TNF/TNFR homologous genes have been described in yeast and Caernohabditis 
elegans, Drosophila melanogaster has one TNF and one TNF receptor homologue. The 
ligand, Eiger, induces JNK-mediated apoptosis, and has been shown to interact physically 
with the receptor, Wengen (Igaki et al. 2002; Kanda et al. 2002; Moreno et al. 2002). The 
homologue of NF-κB in flies, dorsal, is a key component in the determination of dorsal-
ventral polarity and of the innate immune response, but it is activated by a Toll receptor rather 
than TNFRs (Belvin and Anderson 1996). 
 
In vertebrates some of the TNF signalling has more developmental roles (Table 2). The ligand 
RANKL, and its receptor RANK are required for osteoclast differentiation (Dougall et al. 
1999; Hsu et al. 1999; Kong et al. 1999; Suda et al. 1999). Lack of either one causes 
osteopetrosis in transgenic mice. The balance of RANK signalling is controlled at least 
partially by expression of a dominant-negative decoy receptor, osteoprotegerin (OPG) 
(Simonet et al. 1997; Tsuda et al. 1997). An additional function for RANK has been 
discovered also in the later stages of mammary gland differention. In RANKL or RANK null 
mice the mammary gland develops up to puberty but does not differentiate normally during 
pregnancy (Fata et al. 2000). This is due to the lack of NF-κB activation, and specifically the 
lack of the target of NF-κB in mammary gland, cyclin D, which is required for proliferation 
of mammary epithelial cells (Brantley et al. 2001; Cao et al. 2001). OPG also possibly affects 
the vascular system as the presence of OPG in the media of great arteries is believed to protect 
against arterial calcification (Min et al. 2000; Schoppet et al. 2002). Similarly, in endothelial 
cell cultures OPG prevents apoptosis (Malyankar et al. 2000). In the chick limb inhibition of 
NF-κB activity results in a dysmorphic apical ectodermal ridge (AER) (Bushdid et al. 1998; 
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Kanegae et al. 1998). However, it has been proposed that NF-κB is activated indirectly by 
FGF receptors rather than by TNFRs (Bushdid et al. 2001). 
 
NF-κB has also been associated with skin development. Transgenic mice overexpressing NF-
κB subunits have a hypoproliferative epidermis (Seitz et al. 1998). Conversely overexpression 
of IκBα results in epidermal hyperproliferation (Seitz et al. 1998; van Hogerlinden et al. 
1999). IκBα null mutant mice also have defective formation of the epidermis (Beg et al. 
1995; Klement et al. 1996). It is unclear though whether NF-κB signalling is directly involved 
in epidermal proliferation or whether the defects seen are secondary and due to an 
inflammatory response (Kaufman and Fuchs 2000; Pasparakis et al. 2002a). IKKα is required 
for differentiation of the epidermis but as already mentioned this seems to occur by an NF-
κB-independent mechanism (Hu et al. 1999b; Li et al. 1999a; Takeda et al. 1999; Hu et al. 
2001). The role of TNF signalling in ectodermal organ development has recently been 
discovered (for review see Mikkola and Thesleff 2003), and will be discussed in more detail 
in the following results and discussion. 
 
 
Ligands Defects of the immune Other defects Corresponding human References
system disease/OMIM number
TNFα B-cell areas in speen - - Pasparakis et al. 1996
defective, suspectible Marino et al. 1997
to infection Taniguchi et al. 1997
LTα Peripheral lymphoid organs - - De Togni et al. 1994
missing Banks et al. 1995
LTβ Peripheral lymphoid organs - - Koni et al. 1997
missing
FasL Impaired T-cell death Mammary gland Autoimmune lymphoprolife- Takahashi et al. 1994
involution defect rative syndrome / 601859 Song et al. 2000
CD40L B-cell differention defective Possible association Immunodefeciency with Xu et al. 1994
with Alzheimer's hyper -IgM / 308230 Tan et al. 2002
disease
OX40L Defective T-cell response - - Murata et al. 2000
4-1BBL Defective T-cell response, - - DeBenedette et al. 
suspectible to infection 1999
TRAIL Impaired T-cell death Suspectible to tumor - Cretney et al. 2002
metastasis Lamhamedi-Cherradi
et al. 2003
BAFF Required for B-cell - - Schiemann et al. 2001
development
LIGHT Impairment of T-cell - - Tamada et al. 2002
function
Ectodysplasin - Ectodermal dysplasia X-linked HED or EDA Falconer 1952
/ 305100
RANKL T- and B-cell differentiation Osteopetrosis - Kong et al. 1999
defect, missing lymph nodes Mammary gland differentia- Fata et al. 2000
tion
Table 2. Phenotypes of mice lacking TNF/TNFR superfamily genes
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2. AIMS OF THE STUDY 
 
In order to study the early common aspects of ectodermal organogenesis this thesis work 
focused on the analysis of the natural mouse mutant Tabby, which was known to affect the 
development of several ectodermal organs. Specifically the aims were: 
 
- to clone and characterise the Tabby gene. 
 
- to analyse the molecular pathogenesis of the phenotype of the Tabby teeth. 
 
- to study the expression patterns of ectodysplasin (Tabby), its receptor Edar, and a related 
TNF receptor TNFRSF19 during mouse embryogenesis. 
 
- to study the downstream effects of Edar signalling by misexpression of Edar in transgenic 
mice. 
 
Receptors Defects of the immune Other defects Corresponding human References
system disease/OMIM number
TNFR1 B-cell areas in spleen - Familiar periodic fever Pfeffer et al. 1993
defective, suspectible to  / 142680 Rothe et al. 1993
infection Le Hir et al. 1996
TNFR2 - Reduced sensitivity to TNF - Erickson et al. 1994
induced cell death
LTβR Peripheral lymphoid - - Fütterer et al. 1998
organs missing
Fas Impaired T-cell death Mammary gland Autoimmune lymphoprolife- Watanabe-Fukunaga
involution defect rative syndrome / 601859 et al. 1992
Song et al. 2000
CD30 Impaired T-cell death - - Amakawa et al. 1996
CD40 B-cell differention defective, - Immunodefeciency with Castigli et al. 1994
lymphoid follicles small, hyper -IgM / 606843 Kawabe et al. 1994
germinal centers missing
OX40 Defective T-cell - - Kopf et al. 1999
response
4-1BB T-cell response - - Kwon et al. 2002
slightly decreased
BAFF-R Required for B-cell - - Thompson et al. 2001
development
TACI Regulation of B-cell - - von Bulow et al. 2001
proliferation Yan et al. 2001
DR3 Partially impaired T-cell - - Wang et al. 2001
death
DR6 Defective T-cell - - Liu et al. 2001
response Zhao et al. 2001
Edar - Ectodermal dysplasia Autosomal and dominant Philips 1960
HED / 224900, 129490
RANK Missing lymph nodes Osteopetrosis Polyostotic osteolytic dys- Dougall et al. 1999
Mammary gland plasia / 174810; Paget dis- Fata et al. 2000
differentiation ease of bone / 602080
OPG - Osteoporosis, arterial Juvenile Paget disease / Bucay et al. 1998
calcification 239000
NGFR - Defective sensory - Lee et al. 1992
neuron innervation
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3. MATERIALS AND METHODS 
 
3.1. Mouse strains 
 
Strain Used in article Purpose 
NMRI or CBAT6T6 x NMRI I,II,III,IV mRNA expression studies 
Tabby (B6CBACa-Aw-J/A Ta/0 
Jackson Laboratory, Bar 
Harbor, USA) 
I,II,III Analysis of Tabby phenotype 
FVB V Control strain for K14-Edar mice 
K14-Edar V Misexpression of Edar in the ectoderm 
under the keratin 14 promoter 
 
Generation of Ta-βgal mice 
 
Vector pBGbgal was constructed by inserting BglII-XbaI excised beta-galactosidase gene from pTKβ (Clontech) 
into BamHI-XbaI sites of pBS SK+ (Stratagene).  Α blunted NcoI-SmaI fragment from the mouse ectodysplasin 
promoter (nt 272-2517, GenBank accession number Y13438) was excised from plasmid pGL3-Tabby and cloned 
into the blunted XhoI site of pBGbgal. The transgenic construct was released from the vector by partial digestion 
with KpnI and SacI, and microinjected into the pronucleus of FVB mouse fertilized oocytes. Transgenic animals 
were identified by PCR using primers 5'-ACCTCCTCCCTCATTCCCTCTC-3' for ectodysplasin promoter and 
5'-AGACCAATGCCTCCCAGACC-3' for beta-galactosidase gene. Four founders were obtained of which three 
exhibited LacZ staining in a nearly identical manner and one did not express beta-galactosidase. 
 
3.2. Ectodysplasin clones 
 
 
cDNA 
clones 
Source Description Article 
Ta-A1 Mouse E17 5’ stretch 
cDNA library (Clontech) 
Ectodysplasin-A1 partial cDNA (3995 bp) 
subcloned into pCR2.1 (Invitrogen). 
Complete cDNA sequence, AF016628 
(GenBank), was obtained by combining 
with 3’ sequence of clone D85 (Research 
Genetics, USA). 
I 
Ta-A2 Mouse E17.5 cDNA 
library (Clontech) 
Ectodysplasin-A2 cDNA (4937 bp) 
subcloned into pGEM5Z (Promega). 
EMBL accession number AJ243657. 
II 
Ta-A3 Mouse E17.5 cDNA 
library (Clontech) 
Ectodysplasin-A2 cDNA (3096 bp) 
subcloned into pGEM5Z (Promega). 
EMBL accession number AJ243658. 
II 
Ta-B Mouse E17 5’ stretch 
cDNA library (Clontech) 
Ectodysplasin-B cDNA (1879 bp) 
subcloned into pCR2.1 (Invitrogen). 
GenBank accession number AF016630. 
I 
Ta-C Mouse E17 5’ stretch 
cDNA library (Clontech) 
Ectodysplasin-C cDNA (1562 bp) 
subcloned into pCR2.1 (Invitrogen). 
GenBank accession number AF016631. 
I 
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Genomic 
clones 
Source Description Article 
G2 129Sv mouse genomic 
lambda library 
(Stratagene) 
Genomic DNA covering at least 7 kB of 
the Tabby promoter, exon 1 and intron 1 
cloned in lambda FIXII (Stratagene). 
I 
pTEX2 129Sv mouse genomic 
lambda library 
(Stratagene) 
A 646 bp Tabby promoter XbaI-XbaI 
fragment (nt 1-646 of EMBL accession 
number Y13438) subcloned into 
pGEM3Z (Promega). 
I 
pTEX3 129Sv mouse genomic 
lambda library 
(Stratagene) 
A 1433 bp Tabby promoter EcoRI-XbaI 
fragment (nt 650-2083 of EMBL 
accession number Y13438) subcloned 
into pGEM3Z (Promega). 
I 
pTEX6 129Sv mouse genomic 
lambda library 
(Stratagene) 
A 1476 bp Tabby genomic XbaI-EcoRI 
fragment (nt 2084-3560 of EMBL 
accession number Y13438) covering 
exon 1 and containing 614 bp of intron1 
subcloned into pGEM3Z (Promega). 
I 
pGL3-
Tabby 
129Sv mouse genomic 
lambda library 
(Stratagene) 
A 2499 bp NcoI-NcoI genomic fragment 
(nt 51-2550 of EMBL accession number 
Y13438) ending at the translational start 
site cloned into pGL3 (Promega). 
Unpublished 
results 
 
 
3.3. Probes 
 
The following probes were used for in situ hybridisation: 
 
Probe Description or reference Used in: 
Ectodysplasin 
pTaNoBg 
398 bp ectodysplasin cDNA fragment. Described in I. Recognizes 
all ectodysplasin splice forms. 
I,II,III 
Ectodysplasin 
PTE2A 
793 bp ectodysplasin-A3 3’UTR fragment. Described in II. 
Recognizes all ectodysplasin-A splice forms. 
I,II 
Ectodysplasin, pTaB 806 bp ectodysplasin-B cDNA fragment. Described in II. II 
Ectodysplasin 
pTaNcSp 
Laurikkala et al. 2001 (1836 bp). Recognizes all ectodysplasin 
splice forms. 
IV 
Edar 
PTOPOdl 4/3 
1224 bp Edar cDNA. Described in IV. IV 
Edar 
PTOPOdl 3 
Laurikkala et al. 2001 (1415 bp) V 
Bmp2 Vainio et al. 1993 III 
Bmp4 Vainio et al. 1993 III,V 
Egfr Murine cytoplasmic domain of Egfr cDNA in pCRTMII 
(Invitrogen). Gift of David C. Lee. 
III 
Fgf3 Wilkinson et al. 1988 III 
Fgf4 Jernvall et al. 1994 III 
Fgf8 Heikinheimo et al. 1994 III 
Fgf10 Bellusci et al. 1997 III 
Lef1 Travis et al. 1991 V 
L-fng Harada et al. 1999 III 
Patched Kim et al. 1998 V 
p21 740 bp fragment of murine cDNA. Gift of Bert Vogelstein. V 
Shh Vaahtokari et al. 1998a III 
TNFRSF19 365 bp PCR fragment from murine TNFRSF19 (nt 1374-1738, 
GenBank accession number AB040432) cloned into pCRII-TOPO 
(Invitrogen) 
IV 
Wnt10a Dassule and McMahon 1998 III 
  24 
3.4.1. Methods used in articles I-V 
 
Method Article 
Generation and analysis of K14-Edar mice V 
Screening of genomic and cDNA libraries, 
cloning, and sequencing 
I,II 
Tissue culture and bead experiments III 
Analysis of adult mouse tooth phenotype 
(skeletal preparations) 
III 
Histology I,II,III,IV,V 
Radioactive in situ hybridisation on 
sections 
I,II,III,IV,V 
Whole mount in situ hybridisation III,IV,V 
Immunohistochemistry III 
 
 
3.4.2. LacZ staining 
 
LacZ staining was performed essentially as in standard protocols using 2% paraformaldehyde and 0.2% 
glutaraldehyde as fixative, either on whole mount tissues or on 7 µm cryosections. Cryosections were 
counterstained with Nuclear Fast Red. 
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4. RESULTS AND DISCUSSION 
 
4.1. Cloning of the Tabby gene (I, II) 
 
The human X-linked HED gene was positional cloned in 1996 (Kere et al. 1996) but at the 
time only one cDNA was isolated. The coding sequence corresponded to a short 135 aa type 
II membrane protein. The extracellular portion contained four Gly-X-X repeats reminiscent of 
collagens but no other functional domains. Based on these results two strategies were adopted 
in cloning the mouse homologous gene, Tabby, from a mouse E17 embryo cDNA library 
(Clontech). In the first strategy the full-length human cDNA was used as a probe, and five 
cDNAs were recovered. These corresponded to three different splice forms (Ta-A1, Ta-B, Ta-
C). The human EDA-B splice form was also cloned. In the second strategy the mouse genomic 
region was first recovered by probing a mouse genomic library with a 120 bp PCR fragment 
obtained from mouse DNA with primers specific for human EDA intron 1 sequence (nt 4497-
4617 of GenBank accession number U59227). Seven positive lambda clones were recovered 
and one (G2) was subcloned into plasmids (pTEX2, pTEX3, pTEX6). The plasmid clones 
obtained were sequenced and together with sequence obtained from PCR of G2 the sequence 
was compiled into a contig of 3560 bp. An exon homologous to the human exon 1 was 
identified. The 1.5 kb insert from pTEX6 including this exon was used as a probe for 
screening an embryonic cDNA library. Two novel splice forms were obtained (Ta-A2, Ta-
A3). 
 
Simultaneously with the cloning of these Tabby splice forms, the cloning of yet another splice 
form (Ta-A4) was reported (Ferguson et al. 1997). All in all, six different splice variants have 
been recovered (Figure 4a), none corresponding to the originally isolated human cDNA, 
which was named EDA-O. Human cDNAs complementary to mouse cDNAs (EDA-A1, EDA-
A2, EDA-C) have since been discovered together with three novel uniquely human splice 
forms (Figure 4b) (Bayés et al. 1998). 
 
Analysis of the open reading frames (ORF) of all splice forms (mouse and human) showed 
that the N-terminus including a short circa 40 aa intracellular domain, a circa 20 aa 
transmembrane domain, and 71 aa extracellular sequence was shared between all splice 
forms, and was coded by one exon. The configuration was predicted to a type II membrane 
protein. The protein product was named ectodysplasin. A special feature of all the Ta-A splice 
forms was that they contained in their C-terminus an interrupted stretch of 19 Gly-X-X 
repeats and a large TNF domain (Figure 5). A furin cleavage site has subsequently been 
identified between the transmembrane domain and the Gly-X-X repeats (Pääkkönen et al. 
2001), and proteolytic cleavage has been shown to be required for protein activity (Chen et al. 
2001; Elomaa et al. 2001; Schneider et al. 2001). The TNF domain was found to be most 
homologous to the TNF ligands APRIL, TRAIL, and lymphotoxin-α (LT-α) (26% identity). 
Homology to the TNF superfamily was also confirmed by others (Copley 1999; Ezer et al. 
1999). The four Ta-A forms differ from each other by small 2-14 aa deletions in the TNF 
domain. These deletions have been shown to change the receptor-binding properties of the 
ligands (see below). The function of the shorter splice forms that do not contain a TNF 
domain or Gly-X-X repeats has not been determined. Expression of Ta-B mRNA was 
examined with in situ hybridisation in E7 embryos and in the embryonic brain but no signal 
was recovered. In Northern analysis the main transcript is 5.5-6.0 kb long but a shorter 
mRNA has been seen in adult testes (2.4 kb). 
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Figure 4. Murine and human EDA (ectodysplasin) splice forms. 
 
Six Tabby (A) and eight human Eda (B) mRNA isoforms have been discovered. Numbers refer to amino acids. 
COOH, carboxyterminus; COL, collagen-like Gly-X-X repeats; NH2, aminoterminus; TM, transmembrane 
domain; TNF-domain, tumor necrosis factor homology domain. Deletions in the TNF-domain of the A2-A4 
forms are indicated with black bars. Hatched box refers to transcript derived from intron 1. 
 
 
 
 
 
 
 
Figure 5. Ectodysplasin is a TNF ligand. 
 
The N-terminus of ectodysplasin is located 
intracellularly. The extracellular part contains a 
furin cleavage site, a collagen-like domain (COL), 
and a TNF domain. 
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At the same time the genes for the autosomal HED and the downless mouse mutant were 
identified and found to code for a member of the TNF receptor superfamily (Headon and 
Overbeek 1999; Monreal et al. 1999). The 448 aa protein was named Edar for EDA-receptor. 
Like many TNF receptors it contains a death domain in its intracellular domain. Studies of 
ligand binding have shown that Edar specifically binds the ectodysplasin-A1 isoform (Tucker 
et al. 2000; Yan et al. 2000; Elomaa et al. 2001; Kumar et al. 2001). Interestingly, the 
ectodysplasin-A2 isoform is incapable of binding Edar due to a mere two aa deletion 
difference in the TNF domain. Instead, it has been shown to bind to a novel TNF receptor, 
Xedar (for X-chromosome located Edar homologue) (Yan et al. 2000). The binding affinities 
of the ectodysplasin-A3 or –A4 splice forms have not been tested. The corresponding human 
cDNAs have not been isolated which might indicate that these isoforms are aberrant splicing 
events rather than mRNAs coding for functional proteins. Indeed, the A4 splice form does 
lack residues conserved in the TNF domain (Ferguson et al. 1997). Mutations found in 
ectodermal dysplasia patients affect either all splice forms or all the ectodysplasin-A forms 
(Pääkkönen et al. 2001; Schneider et al. 2001; Vincent et al. 2001; Drögemüller et al. 2002). 
One exception is an intronic mutation that is predicted, but not shown, to specifically affect 
ectodysplasin-A1 splicing (Schneider et al. 2001). In summary, it can be concluded that the 
ectodysplasin-A1 – Edar signalling pathway is responsible for the ectodermal dysplasia 
phenotype in mice and humans. The importance of ectodysplasin-A2 –Xedar signalling is 
unclear. Xedar is expressed at later stages of hair follicle formation, and the A2 protein 
isoform also has been localised at later stages using a labelled Xedar-fusion protein for 
detection (Yan et al. 2000). Unlike ectodysplasin-A1, neither ectopic expression of the 
ectodysplasin-A2 isoform in transgenic mice nor prenatal treatment with ectodysplasin-A2 
protein effected development or rescued the Tabby phenotype (Gaide and Schneider 2003; 
Mustonen et al. 2003). 
 
4.2. Analysis of Tabby tooth phenotype and partial rescue by FGF (III) 
 
The Tabby tooth phenotype is strongly influenced by the genotype or the mouse background 
strain (Grüneberg 1965). The dental phenotype of our Tabby strain, which was in a B6CBA 
hybrid background, was analysed first morphologically. 23% of the mice had missing incisors 
(N=26) and third molars were missing in 17% of half-mandibles (N=52). The cusp number of 
the first lower molar was reduced to an average of 3.8 cusps in contrast to the seven cusps of 
wild type mice. Tabby tooth development was also studied in in vitro cultures started at E13 
and E14. Although the in vitro cusp numbers achieved were lower than in vivo (seven wild 
type in vivo cusps compared to five in vitro), Tabby molars developed in vitro comparably to 
in vivo as the first molar cusp number was reduced (three cusps on average). The mesio-distal 
length of the first molar tooth germ was one-third shorter than wild type tooth germs. 
Peterkova and colleagues have subsequently studied Tabby tooth germs using three-
dimensional reconstructions of histological sections (Peterkova et al. 2002). They have 
observed a range of different Tabby morphotypes. Although the mesio-distal length of the 
entire dental epithelium in their study was similar to wild type mice, the first molar (or the 
most mesial tooth) primordia were consistently shorter agreeing with the in vitro data in 
article II. 
 
Injections of EGF into neonate Tabby mice have been shown to induce sweat gland formation 
(Blecher et al. 1990). In order to test whether EGF could also rescue the tooth defect of Tabby 
mice, Tabby molars were cultured in vitro together with EGF in the medium. This had no 
effect on Tabby tooth development. Instead, addition of FGF10 to media increased Tabby 
cusp number to 3.6 at E13 (compared to 2.8 without FGF10) and to 4.3 at E14 (compared to 
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3.4 without FGF10). FGF10 is normally expressed in the dental mesenchyme (Kettunen et al. 
2000), and its receptors, Fgfr1b and Fgfr2b, are expressed in the epithelial cervical loops 
(Kettunen et al. 1998). Mesenchymal FGFs have been shown to enhance epithelial 
proliferation, and it is possible that the increase in epithelial proliferation in Tabby teeth may 
have caused the increase in cusp number. On the other hand, a link between FGFs and NF-κB 
signalling has been observed. In the chick limb the AER seems to be required for the 
expression of c-rel, an NF-κB subunit, in the progress zone. Exogenously applied FGF4 can 
substitute for this requirement (Bushdid et al. 1998; Kanegae et al. 1998). Furthermore, NF-
κB is required for FGF mediated induction of Msx1 in the AER (Bushdid et al. 2001). As 
Edar also can activate NF-κB signalling (Yan et al. 2000; Koppinen et al. 2001; Kumar et al. 
2001), it is not impossible that FGF10 may have contributed to the downstream effects of NF-
κB signalling in Tabby teeth. FGF4 and FGF10 do not bind to the same receptors, but this 
nevertheless does not rule out the possibility of them regulating NF-κB signalling similarly. 
 
In situ hybridisation analysis with markers for early bud- and cap-stage teeth showed that 
signal molecules associated with tooth development such as Fgf4, Wnt10a, L-fng, Fgf3, 
Fgf10, and Egfr were present in Tabby teeth. The size of the enamel knot was smaller 
correlating with the reduced number of cusps in adult teeth. This gives support to the 
hypothesis of the enamel knot being a signalling centre and determining tooth shape (Jernvall 
et al. 1994; Vaahtokari et al. 1996a). 
 
4.3. Expression of ectodysplasin and Edar (I,II,III,IV, unpublished results) 
 
Localisation of ectodysplasin and Edar mRNAs was studied with in situ hybridisation (see 
Table 3 for a summary of expression results). A combination of probes for ectodysplasin 
mRNA was used that recognised either all ectodysplasin splice forms (exon 1) or specifically 
Ta-A or Ta-B isoforms. The first results with probes for exon 1 or Ta-A 3’ terminus showed 
expression of ectodysplasin in the outer enamel epithelium in cap and bell stage tooth molars 
and in E14 epidermis prior to hair follicle formation. The expression patterns for exon 1 and 
Ta-A specific probes were identical suggesting that Ta-A splice forms are the major splice 
forms. Subsequently the detection for ectodysplasin mRNA was improved as a full-length 
cDNA probe was utilized. Comparison of ectodysplasin and Edar expression in embryonic 
tooth and skin revealed that ectodysplasin and Edar were both expressed in early oral and skin 
epithelium prior to placode formation (Laurikkala et al. 2001, 2002). Concomitant with 
placode formation Edar localised to the ectodermal placode but ectodysplasin expression 
continued in the intervening epithelium. Later Edar was seen in the dental signalling centres 
and in the hair bulb. Ectodysplasin continued to be expressed in adjacent epithelial tissues. 
The adjacent expression provoked the suggestion that ectodysplasin-Edar signalling mediates 
epithelial-epithelial communication (Laurikkala et al. 2001). Diffusion of ectodysplasin is 
likely to occur between these compartments as it is cleaved in the stalk region by furin and 
shed extracellularly (Chen et al. 2001; Elomaa et al. 2001; Schneider et al. 2001). This 
shedding is obligatory for the function of the protein as mutations in the furin cleavage site 
cause the ectodermal dysplasia phenotype in humans (Pääkkönen et al. 2001; Schneider et al. 
2001; Vincent et al. 2001). 
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A comparison of ectodysplasin and Edar expression in tissues other than tooth and skin was 
conducted (Table 3). In the early mouse embryo ectodysplasin-A but not the B isoform was 
expressed in the visceral and definitive endoderm. No Edar was detected though (unpublished 
results). The developing brain showed a dynamic pattern of ectodysplasin and Edar 
expression. At some but not all locations the mRNA expression was complementary but never 
overlapping. Ectodysplasin localised to the lateral ventricles, thalamus, Rathke’s pouch, 
hindbrain, and to the ventral neuroepithelium along the mid-hindbrain border. It was also seen 
in some locations in the cranial mesenchyme. Edar was expressed in the diencephalon, lateral 
ventricles, ganglionic eminence, thalamus, and midbrain. Complementary expression patterns 
with ectodysplasin were seen in the thalamus, lateral ventricles, and midbrain. In the lacrimal 
glands ectodysplasin was expressed in the corneal epithelium and the Edar in the adjacent 
conjunctival epithelium and later in the lacrimal gland. In the submandibular salivary gland 
ectodysplasin was expressed in the surrounding mesenchymal tissue and Edar in the epithelial 
bud and branches. 
 
Edar was also detected in the vibrissae epithelium, in the apical ectodermal ridge of the limb 
bud, and in the mammary placodes. Ectodysplasin was expressed in the anterior head 
mesenchyme but not immediately adjacent to the vibrissal Edar expression. In the limb and in 
the mammary epithelium ectodysplasin was not detected but this may reflect the low level of 
ectodysplasin expression rather than the absence of the transcript. 
 
In summary, ectodysplasin and Edar mRNAs were found localised in adjacent epithelial 
compartments in the lacrimal gland, thalamus, midbrain, and lateral ventricles mimicking the 
expression pattern in teeth and hair. Teeth, hair, and lacrimal glands are all tissues that are 
affected in Tabby mice and HED patients. No brain defects are reported as primary symptoms 
although hyperthermia caused by inadequate sweating has been known to cause mental 
Organ Age Ectodysplasin Edar
All splice forms Ta-A Ta-B
Embryo E6 + nd nd -
E7 + + - nd
Rathke's pouch E10 + + - -
E12 + + - -
Brain E10 + + 1) - +
E12 + + 1) - +
Tooth E14 + + - 2)
E15 + + - 2)
E17 + + - 2)
Skin E14 + + nd 3)
E16 3) + nd 3)
E18 3) + nd 3)
Lacrimal gland E12 + nd nd +
E14 + nd nd +
Salivary gland E12 -? nd nd +
E13 + nd nd +
E14 + nd nd +
Mystacial whiskers E12 -? nd nd +
E13 nd nd nd +
Sensory whiskers E13 nd nd nd +
Limb bud E10 nd nd nd +
Mammary gland E12 nd nd nd +
Table 3. Summary of ectodysplasin  and Edar  expression studies in this thesis
+ , expression; -, no expression; -?, expression not detected but sensitivity might not be 
enough; nd, not determined
1) Checked only in the diencephalon, 2) Laurikkala et al. 2001, 3) Laurikkala et al. 2002
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retardation in HED patients (Halperin and Curtis 1942; Clarke et al. 1987). Ectodysplasin has 
been reported to be expressed in the human brain during embryogenesis throughout the 
cerebral neuroepithelium. In the adult human brain Eda-positive neurons were found in the 
hypothalamus (Montonen et al. 1998). Secondly, ectodysplasin and Edar were expressed in 
adjacent epithelial and mesenchymal compartments in the developing submandibular gland at 
E13 and E14. The expression pattern suggests signalling between the epithelium and 
mesenchyme, and is the first indication of ectodysplasin-Edar signalling between epithelial 
and mesenchymal compartments. Ectodysplasin and Edar localisation has been studied in the 
submandibular gland using immunohistochemistry (Jaskoll et al. 2003). In these studies 
protein expression was not detected until E15. This may reflect either poor sensitivity of 
antibodies used or the fact that the proteins need not be translated until then. Ectodysplasin 
was localised to epithelial surfaces, which of course is necessary for signal transduction even 
if the mRNA is produced in the mesenchyme. Defective salivary glands are found in Tabby 
mice and HED patients (Blecher et al. 1983; Nordgarden et al. 2001). Thirdly, isolated 
expression of either the ligand or the receptor was seen in some tissues. For example, 
ectodysplasin was strongly expressed in the epithelial component of the developing pituitary 
gland, but no Edar was present. At least four different possibilities may account for these 
cases. First, expression of the mRNA need not result in expression of a functional and 
developmentally significant protein. Secondly, detection with in situ hybridisation may not be 
sensitive enough to detect low-level transcripts. Particularly ectodysplasin has been extremely 
difficult to detect. For example, Edar is expressed in the mystacial vibrissae but no localised 
ectodysplasin mRNA is seen in the vibrissae. Nevertheless, vibrissae of Tabby mice are 
defective to some degree suggesting that the ectodysplasin ligand must be present (Dun 
1959). A third possibility is that ectodysplasin may signal via the Xedar receptor since 
ectodysplasin-A2 binds Xedar. Comprehensive Xedar expression patterns have not been 
reported and our attempts to localise Xedar mRNA in tissue sections have not been 
successful, leaving this possibility still open. The last alternative is that Edar binds a second 
ligand in addition to ectodysplasin. This has been suggested by the dissimilarity of the 
submandibular gland phenotypes of Tabby and downless mice (Jaskoll et al. 2003). Also it has 
been postulated that a phenotypic difference is seen in the enamel knot of Tabby and downless 
mice (Tucker et al. 2000). However, no such ligand has been found as yet. 
 
4.4. Expression of TNFRSF19 (IV) 
 
Given the large number of members of the TNFR superfamily, it is possible that other TNF 
signalling apart from ectodysplasin-Edar is also active during ectodermal organogenesis. 
Since the ectodysplasin and Edar null mutant phenotypes are fairly mild, it has been suggested  
that redundancy with other TNF receptors might account for the lack of a more severe 
phenotype (Mikkola and Thesleff 2003). TNFRSF19, also known as Troy or Taj, is an orphan 
TNF receptor (Hu et al. 1999a; Eby et al. 2000; Kojima et al. 2000). Its ligand-binding 
domain has a 50% identity with Xedar (Yan et al. 2000; Mikkola and Thesleff 2003), and a 
33% homology to Edar (Kojima et al. 2000). It is expressed in hair follicles, and is thus a 
good candidate for functioning in a similar role as Edar. It should be kept in mind though that 
there are conflicting reports about its ability to activate NF-κB (Eby et al. 2000; Kojima et al. 
2000). 
 
The expression of TNFRSF19 was analysed during mouse embryogenesis and found to 
overlap with Edar in the tooth, vibrissae, limb bud, and mammary gland. In the tooth 
TNFRSF19 is expressed in the dental epithelium from E11 to E17. At the bud stage some 
expression is also seen in the dental mesenchyme. Edar is localised to signalling centres such 
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as the enamel knot during tooth morphogenesis but the expression of TNFRSF19 is more 
widespread. In the developing brain TNFRSF19 was expressed mainly in the dorsal fore- and 
midbrain in contrast to the more ventrally localised Edar expression. 
 
Thus, the expression pattern of TNFRSF19 suggests that it may mediate the same downstream 
signals as Edar in the tooth, vibrissae, limb bud, and mammary gland. The generation of 
TNFRSF19 mutant mice will assist in exploring the function of TNFRSF19. 
 
4.5. Tabby promoter cloning and its analysis in transgenic mice (I and unpublished 
results) 
 
A genomic lambda clone (G2) of approximately 7 kb containing exon 1 of ectodysplasin was 
subcloned. The plasmid clones were sequenced and together with sequence obtained by PCR 
from G2 was assembled into a 3.5 kb contig. Analysis of the 2.5 kb preceding the 
transcription start site revealed a putative binding site for LEF1, which was conserved in the 
human Eda promoter. Homology around the binding site was 96%, and throughout the 
promoter 82%. Due to the apparently low expression levels of ectodysplasin mRNA a 
transgenic construct was generated where a 2.2 kb fragment of the promoter was used to 
direct beta-galactosidase expression. The aim was to further elucidate the ectodysplasin 
expression pattern. Three founders (Ta-βgal ) were obtained which displayed nearly identical 
expression patterns. However, the pattern did not correspond to the endogenous pattern. For 
example, the teeth and hair did not show any staining. Instead, LacZ staining was seen at E10 
in the somites (Figure 6a,b). The expression continued along the vertebra and ribs until at 
least E18 (data not shown). Cranial mesenchyme and lateral ventricles were also positive for 
the transgene, but the staining pattern was different from the endogenous ectodysplasin 
expression in the developing head and brain (Figure 6c). This indicates that the 2.2 kb 
promoter fragment is not sufficient for reproducing endogenous ectodysplasin expression. 
Comparison of the long intron I sequence (200-300 kb) in both mouse and human 
ectodysplasin genes may reveal enhancer elements required for transcriptional regulation 
(GenBank accession number NT_039711; Kere et al. 1996). 
 
 
 
                               
 
Figure 6. Tabby promoter betagalactosidase staining. 
 
LacZ staining pattern of the Ta-βgal mice. (A,B) Transgene activity is seen in the anterior head mesenchyme and 
in the somites at E10. (C) Lateral ventricles (arrows) and the cranial mesenchyme are positive for beta-
galactosidase at E12. (A,B) Whole mount LacZ staining. Scale bar for A, 1 mm, for B, 200 µm. (C) Frontal 
cryosection stained with Xgal. Scale bar, 500 µm. 
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4.6. Overexpression of Edar in transgenic mice (V and unpublished results) 
 
Ectodysplasin can form trimers (II; Ezer et al. 1999; Schneider et al. 2001) like other 
members of the TNF ligand superfamily and when transfected to cells it activates the NF-κB 
pathway (Yan et al. 2000; Koppinen et al. 2001; Kumar et al. 2001). The genes activated by 
NF-κB and the downstream cellular effects are not understood. In an attempt to study Edar 
signalling transgenic mice were generated where the keratin 14 (K14) promoter directed 
expression of Edar in the basal epidermis, the outer root sheath of the hair follicle and the oral 
epithelium. In comparison to the endogenous expression transgenic Edar was seen first 
similarly in the developing epithelium albeit at higher levels, and thereafter the expression 
continued throughout the epithelium and was not confined to the forming placodes. 
 
First, the phenotype of the transgenic mice depended heavily on the expression levels. The 
mice could be grouped into two main groups: strong and weak expression based on the 
transgene copy number and the protein expression levels. In addition, there were some 
intermediate types. Tissues affected by the misexpression included hair, teeth, nails, and 
mammary glands. 
 
The main effect on the teeth was the change in cusp number and molar tooth shape. 
Surprisingly, different levels of Edar signalling in the oral epithelium had opposite effects on 
tooth morphology. Mice expressing Edar weakly had a reduced number of cusps, whereas 
strongly expressing mice an additional cusp. It is possible that the balance of promoters and 
inhibitors is very easily disturbed by subtle changes in Edar signalling. On the other hand, it 
cannot be ruled out that timing of the K14 promoter activity might be different in the weak 
and strong founder lines thus having a different effect on the enamel knot, which then results 
in different tooth shapes. 
 
In addition, the tooth enamel was defective in the strong expression group. The phenotype 
was very similar to that observed with overexpression of ectodysplasin-A1 under the K14 
promoter (Mustonen et al. 2003). Defective enamel can result from errors at different stages 
of amelogenesis and it is not clear what causes the enamel phenotype in Edar or 
ectodysplasin-A1 overexpressing mice. A curious detail is the similarity of the enamel defects 
with a transgenic mouse expressing the serine protease urokinase-type plasminogen activator 
in the oral and enamel epithelium (Zhou et al. 1999). It is therefore possible that Edar might 
regulate the proteolytic balance in amelogenesis. The fact that Edar signalling can have 
different effects in different tissues, e.g. lack of differentiated cells in the tooth, or promotion 
of ectopic organ formation (mammary gland, Mustonen et al. 2003), further stresses the 
importance of the cellular context for the downstream effects of TNF signalling.  
 
The primary hair follicle (guard hair) defect was analysed in more detail. At E15 wild type 
mice have primary hair placodes. The strong expression K14-Edar mice had no primary hair 
follicles and the weak expression group had reduced numbers. This was reflected by the 
relative proportion of hair types in adult mice: the strong group had no guard hairs, and 1% of 
all hairs in the weak group were guard hairs. Control mice had 2% guard hairs. Later at E17 
hair development commenced. However, in adult mice of the strong group the three 
remaining hair types did not differentiate properly as all the remaining hairs looked alike. 
Superficially they appeared to be awls, but they were shorter than awls and did not contain the 
characteristic air cell pattern typical for awls. Hairs of the tail were also shorter. 
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Molecular analysis showed the lack of placode markers at E15 epidermis. However, BMP4, 
which is normally expressed first throughout the mesenchyme and is then restricted to the 
placodal mesenchyme, remained expressed in the entire mesenchyme underlying the 
epithelium. This expression continued at least until newborn. Since Edar was expressed in the 
epithelium, BMP4 could not have been a direct target gene for Edar activated NF-κB. 
Nevertheless it is the first molecule shown to be upregulated as a consequence of Edar 
signalling. p21, which has been shown to be a target of BMP signalling (Jernvall et al. 1998), 
was also upregulated in K14-Edar mesenchyme.  
 
Misexpression of Edar in the developing epithelium resulted in a loss of primary hair follicle 
formation. This could be caused by Edar activity in the interfollicular epithelium. The 
upregulation of BMP, which is a known inhibitor of hair follicle formation (Botchkarev et al. 
1999), might inhibit placode formation. At present it has not been shown that Edar is truly 
active in the interfollicular area. However, the upregulation of Bmp4 throughout the 
mesenchyme suggests activity. In Tabby epidermis Bmp4 is downregulated at E15 even if the 
hair phenotype, lack of primary follicles, is similar (Laurikkala et al. 2002). 
 
 
5. CONCLUDING REMARKS 
 
The signalling pathways responsible for ectodermal organ developing are being at least 
partially unravelled at the moment. Members of the common growth factor families FGF, 
BMP, Shh, and Wnt seem to play major roles similarly as they play in the development of the 
early embryo and in the organogenesis of other organs as well. In C. elegans there is some 
evidence that organ-specific regulators exist (Gaudet and Mango 2002). The fact that 
mutations in five genes of the TNF signalling pathway turned out to be responsible for 
ectodermal dysplasias suggests that at least some members of the TNF family are specifically 
required for ectodermal organogenesis. 
 
This work has focused on the ectodysplasin-Edar pathway in epithelial morphogenesis. This 
pathway is required for the development of teeth, hairs, sweat glands, salivary glands, 
lacrimal glands, and a large group of smaller glands, mainly in the nasal, oral, and pharyngeal 
area (Grüneberg 1971). In addition to vertebrates, Edar signalling is also required for 
ectodermal organogenesis in other species, as Edar mutations in Medaka fish result in lack of 
scale development (Kondo et al. 2001). It cannot be ruled out, however, that ectodysplasin-
Edar signalling is utilised also in other organs. For example, the developing limb shows 
coexpression of Edar and TNFRSF19 in the AER. Ta/dl/cr mice have normally developed 
limbs, but it is possible that other TNF signalling, possibly mediated by TNFRSF19, 
compensate for Edar. NF-κB signalling is required for limb development in the chick 
(Bushdid et al. 1998; Kanegae et al. 1998). 
 
What is known about the regulation of ectodysplasin-Edar signalling? First of all, several 
ectodysplasin mRNA splice forms have been detected, five of them in this study. Four splice 
forms have small changes in the TNF domain. This may affect the binding affinity as has been 
shown for ectodysplasin-A2. The A2 isoform seems to be coexpressed with the A1 isoform at 
later stages of hair follicle development (Yan et al. 2000). Differential regulation of the 
expression of the A3 and A4 isoforms has not been studied. The two shorter isoforms, 
ectodysplasin-B and –C, potentially could act as negative regulators by competing with the 
A1 or A2 isoforms. However, the lack of the TNF domain and the collagen-like Gly-X-X 
repeat capable of participating in multimere formation make this possibility somewhat 
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unlikely. Second, Wnt signalling mediated by LEF1 has been shown to regulate the 
expression of ectodysplasin (Laurikkala et al. 2001, 2002; Durmowicz et al. 2002). This study 
showed that the promoter region containing the LEF1 binding site is not sufficient for 
mimicking endogenous expression. Since a similar phenotype was observed in three separate 
transgenic lines an integration effect can be ruled out. Therefore other enhancer sites and 
transcriptional regulators must contribute to proper expression of ectodysplasin mRNA. 
 
How is Edar signalling mediated? Cloning of the crinkled gene and analysis of its protein 
product showed that the intracellular adapter protein for Edar is Edaradd (Figure 7) (Headon 
et al. 2001; Yan et al. 2002). It contains a DD domain that binds specifically to the DD 
domain of Edar. The similarity of the phenotypes of crinkled, downless, and Tabby mice 
further supports the specificity of Edaradd for Edar. Edaradd can bind TRAF1, -2. or -3 but 
not TRAF4, and only marginally TRAF5 or –6 (Headon et al. 2001; Yan et al. 2002). This is 
somewhat surprising since TRAF6 null mice have ectodermal dysplasia symptoms (Naito et 
al. 2002). However, Xedar does bind to TRAF6 (Naito et al. 2002; Sinha et al. 2002). One 
explanation of the TRAF6 null phenotype is that Xedar signalling is regulated by Edar. 
TRAFs 1-4 and –6 are all expressed in the mouse molar in an overlapping pattern so more 
detailed studies are required to resolve which TRAFs are used by Edar and Xedar (Ohazama 
et al. 2003). Edar can activate the NF-κB pathway (Yan et al. 2000; Koppinen et al. 2001; 
Kumar et al. 2001) but only slightly the JNK pathway (Kumar et al. 2001) indicating that NF-
κB is the main signal transduction pathway of Edar. Further support for this comes from mice 
overexpressing IκB. This inhibition of NF-κB signalling resulted in an ectodermal dysplasia 
phenotype remarkably similar to Tabby mice (Schmidt-Ullrich et al. 2001). Moreover, IKKγ 
is required for Edar signalling (Döffinger et al. 2001). Human patients having hypomorphic 
mutations in IKKγ or lacking one copy of IKKγ display ectodermal dysplasia symptoms in 
addition to osteopetrosis and immune defects (Smahi et al. 2002; see also Table 1 for 
references). Complete lack of IKKγ in mice is lethal (Rudolph et al. 2000). 
 
                     
 
Figure 7. Schematic view of Edar and Xedar signalling. 
 
Eda-A1 (ectodysplasin-A1) binds specifically to Edar, which recruits the adaptor protein, Edaradd. Edaradd can 
bind to TRAF1-3, and slightly to TRAF5 and -6. IKK complex activates NF-κB transcription factor. It is 
uncertain if Edar signalling can cause cellular death. Eda-A2 (ectodysplasin-A2) binds specifically to Xedar, 
which can directly recruit TRAF3 and -6. Both NF-κB and JNK pathways can then be activated. 
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What is the function of ectodysplasin-Edar signalling in ectodermal organs? What are the 
downstream targets that it regulates? Ectodysplasin has been overexpressed in transgenic mice 
using the K14 promoter (Mustonen et al. 2003). In contrast to overexpression of Edar, 
ectodysplasin is only active at sites where Edar is endogenously expressed, e.g. in hair and 
tooth placodes. In these mice ectopic organ formation is induced. Hair follicles are formed 
continuously, an extra molar is seen mesially to the first molar, and ectopic mammary glands 
are found along the mammary line. Furthermore, the amount of sweat is increased, and nails 
and hairs are longer than in wild type (Mustonen et al. 2003). Therefore Edar signalling can 
affect organogenesis at a relatively early stage, and in a fundamental way. In this work we 
have shown that Tabby molars are smaller than wild type molars and that the enamel knot is 
reduced in size (III). Could ectodysplasin affect proliferation? FGF10 can partially rescue the 
molar phenotype, and FGFs are known enhancers of proliferation. However, overexpression 
of ectodysplasin in the hair placodes does not significantly increase proliferation (Mustonen et 
al. 2003 and unpublished results) suggesting that proliferation may not be a primary response 
of Edar in hair placodes. In addition, Edar is localised to the enamel knot during tooth cap 
stage (Laurikkala et al. 2001). The enamel knot cells do not proliferate further arguing against 
proliferation as a direct effect of ectodysplasin-Edar signalling in the knot either. Apoptosis is 
a possible downstream effect of TNF signalling. Edar does not seem to induce apoptosis in 
cultured cells (Koppinen et al. 2001), although caspase-independent activation of the 
apoptotic pathway has been proposed by one study (Kumar et al. 2001). Tabby and downless 
tooth germs show comparable staining of apoptotic cells (Tucker et al. 2000; Koppinen et al. 
2001). Inhibition of NF-κB signalling with a constitutively active IκBα in transgenic mice 
seems to increase apoptosis of hair follicles, suggesting that the role of NF-κB signalling in 
hair may be anti-apoptotic (Schmidt-Ullrich et al. 2001). It should be kept in mind though that 
as with all TNF signalling, the cellular context may effect Edar signalling, and that the 
downstream responses possibly differ at different stages of organogenesis. 
 
We have also shown that BMP4 is upregulated in K14-Edar dermis (V). There are at least two 
ways of explaining this. First, BMP4 may be an indirect target of Edar signalling. Edar in the 
epithelium activates NF-κB, which then transcriptionally activates an unknown factor, which 
directly or via mediators induces BMP4 expression in the dermis. The other possibility is that 
BMP4 expression, seen throughout the dermis prior to placode formation, remains in a default 
status when primary hair placodes do not form in the transgenic skin. However, the fact that 
BMP4 is missing in Tabby skin of similar age, which also lacks hair placodes, argues against 
this interpretation (Laurikkala et al. 2002). MAdCAM-1, an adhesion molecule, has been 
proposed as a target of Edar signalling since MAdCAM-1 is expressed in hair placodes and 
this expression is missing in Tabby mice (Nishioka et al. 2002). It also has an NF-κB binding 
site in its promoter. No direct evidence to support this exists though. 
 
In summary, since cloning of ectodysplasin in 1997 much has been learned about its 
signalling pathway. Nevertheless, we are forced to return to the original question: what is the 
fundamental function of ectodysplasin in ectodermal organogenesis? It is the task for the next 
few years to put together the missing jigsaw puzzle pieces. A combination of novel techniques 
such as global analysis of gene expression techniques (Cui et al. 2002) and older cell biology 
assays will probably be needed to answer these questions. 
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